CD19 and neoplasm: This suggests that CD19-SynNotchPDbody-CAR T cells could be more locally cytotoxic at the tumor siteand less cytotoxic if they migrated away to other locations wherethey would be scattered with decaying CAR expression,44 which should be beneficial to mitigate the off-tumor toxicityof standard CAR T cells.